Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris

American Journal of Cardiology

Volumn 83, Issue 10, 1999, Pages 1488-1490

  Blum, Arnon ^a   Porat, Reuven ^c   Rosenschein, Uri ^b   Keren, Gad ^b   Roth, Arie ^b   Laniado, Shlomo ^d   Miller, Hylton ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Departments of Cardiology   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; HUMAN; INFLAMMATION; MALE; ORAL DRUG ADMINISTRATION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REBOUND;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ARGININE; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033562825     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00129-0     Document Type: Article

References (20)

1. Moncada S., Higgs A. The L-arginine-Nitric Oxide Pathway. N Engl J Med. 329:1993;2002-2012.
2. Tsao P., McEvoy L., Drexler H., Butcher E., Cooke J. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 89:1994;2176-2182.
3. Creager M., Gallagher S., Girerd X., Coleman S., Dzau V., Cooke J. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. JCI. 90:1992;1248-1253.
4. Drexler H., Zeiher A., Meinzer K., Just H. Correction of endothelial dysfunction in microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 338:1991;1546-1550.
5. Koifman B., Wollman Y., Bogomolny N., Chernichowsky T., Finkelstein A., Peer G., Scherez J., Blum M., Laniado S., Keren G. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol. 26:1995;1251-1256.
6. Lerman A., McKinley L., Higano S., Holmes D. Oral chronic L-arginine administration improves coronary endothelial function in humans. J Am Coll Cardiol. 29:1997;192A.
7. Spertus J., Winder J.T.A., Deyo R., Fihn S. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 74:1994;1240-1244.
8. Spertus J., Winder J., Dehurst T., Deyo R.A., Prodzinski J., McDonell M., Fihn S.D. Development and evaluation of the Seattle Angina Questionnaire a new functional status measure for coronary artery disease . J Am Coll Cardiol. 25:1995;333-341.
9. Van Der Meer J., Endres S., Lonnemann G., Cannon J.G., Ikejima T., Okusawa S., Gelfand J.A., Dinarello C.A. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol. 43:1988;216-223.
10. Lisi P., Koch G., Endres S., Lonnemann G., Dinarello C. Development and use of a radioimmunoassay for human interleukin 1 beta. Lymphokine Res. 6:1987;229-244.
11. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S., Dinarello C. Correlations and interaction in the production of interleukin 6, interleukin 1, and tumor necrosis factor in human blood mononuclear cells interleukin 6 suppresses interleukin 1 and tumor necrosis factor . Blood. 75:1990;40-47.
12. Dubois-Rande J., Zelinsky R., Roudot F., Chabrier P., Castaigne A. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol. 70:1992;1268-1275.
13. Quyyumi A.A., Dakak N., Mulcahy D., Andrews N.P., Husain S., Panza J.A., Cannon R.O. III. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 29:1997;308-317.
14. De Caterina R., Libby P., Peng H., Thannickal V.J., Rajavashisth T.B., Gimbrose M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. JCI. 96:1995;60-68.
15. Kuo L., Davis M., Cannon M., Chilian W. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation restoration of endothelium-dependent responses by L-arginine . Circ Res. 70:1992;465-476.
16. Moilanen E., Vuorinen P., Kankaanranta H., Metsaketela T., Vapatalo H. Inhibition by nitric oxide donors of human polymorphonuclear leukocyte functions. Br J Pharmacol. 109:1993;852-858.
17. Wolf A., Zalpour C., Theilmeir G., Wang B.Y., Ma A., Anderson B., Tsao P.S., Cooke J.P. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 29:1997;479-485.
18. Chauhan A., More R., Mullins P., Taylor G., Petch M., Schofield P. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol. 28:1996;1796-1804.
19. Adams M., Jessup W., Hailstones D., Celemajer D. L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation. 95:1997;662-668.
20. Peng H, Libby P, Liao J. Induction and stabilization of IkB by nitric oxide mediates inhibition of NFkB. J Biol Chem1995;270:14214-14219.